Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | RAD52 | P43351 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 3/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1685669 | 1.00 | HCAR2 (0.56) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL808734 | 0.98 | HCAR2 (0.55) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL809044 | 0.92 | ATM (0.61) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL9419493 | 0.90 | TSHR (0.52) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL27324595 | 0.84 | ATM (0.52) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL1305378 | 0.78 | HCAR2 (0.85) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL7780534 | 0.78 | HCAR2 (0.85) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL9318682 | 0.78 | HCAR2 (0.85) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL18209632 | 0.78 | HCAR2 (0.85) | HCAR2ATMNAAATSHRHPGD | |
| SCHEMBL357423 | 0.78 | HCAR2 (0.85) | HCAR2ATMNAAATSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12571157-B2 | Fluorocarbon chain-free hydrophobic fabric, preparation and application thereof | SOOCHOW UNIVERSITY (CN) | 2026-03-10 | — | — | US | claimed |
| US-20240344264-A1 | FLUOROCARBON CHAIN-FREE HYDROPHOBIC FABRIC, PREPARATION AND APPLICATION THEREOF | SOOCHOW UNIVERSITY (CN) | 2024-10-17 | — | — | US | claimed |
| WO-2023155308-A1 | FLUORINE-FREE CARBON CHAIN HYDROPHOBIC FABRIC, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 苏州大学 | 2023-08-24 | — | — | WO | claimed |
| US-12571157-B2 | Fluorocarbon chain-free hydrophobic fabric, preparation and application thereof | SOOCHOW UNIVERSITY (CN) | 2026-03-10 | — | — | US | disclosed |
| US-12571157-B2 | Fluorocarbon chain-free hydrophobic fabric, preparation and application thereof | SOOCHOW UNIVERSITY (CN) | 2026-03-10 | — | — | US | disclosed |
| US-20250092008-A1 | PROCESS FOR MAKING AN EP4 ANTAGONIST | ONO PHARMACEUTICAL CO., LTD. (JP) | 2025-03-20 | — | — | US | disclosed |
| US-20240344264-A1 | FLUOROCARBON CHAIN-FREE HYDROPHOBIC FABRIC, PREPARATION AND APPLICATION THEREOF | SOOCHOW UNIVERSITY (CN) | 2024-10-17 | — | — | US | disclosed |
| US-20240344264-A1 | FLUOROCARBON CHAIN-FREE HYDROPHOBIC FABRIC, PREPARATION AND APPLICATION THEREOF | SOOCHOW UNIVERSITY (CN) | 2024-10-17 | — | — | US | disclosed |
| EP-4384509-A1 | PROCESS FOR MAKING AN EP4 ANTAGONIST | ONO Pharmaceutical Co., Ltd. (JP) | 2024-06-19 | — | — | EP | disclosed |
| WO-2023155308-A1 | FLUORINE-FREE CARBON CHAIN HYDROPHOBIC FABRIC, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 苏州大学 | 2023-08-24 | — | — | WO | disclosed |
| WO-2023155308-A1 | FLUORINE-FREE CARBON CHAIN HYDROPHOBIC FABRIC, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 苏州大学 | 2023-08-24 | — | — | WO | disclosed |
| EP-2053037-A1 | PROCESS FOR PRODUCTION OF TRANS-2,2-DIMETHYL- 3-FORMYLCYCLOPROPANE CARBOXYLIC ACID ESTER | Sumitomo Chemical Company, Limited (JP) | 2009-04-29 | — | — | EP | disclosed |
| EP-1950208-A1 | PROCESS FOR PRODUCING 6,6-DIMETHYL-3-OXABICYCLO[3.1.0]HEXAN-2-ONE | Sumitomo Chemical Company, Limited (JP) | 2008-07-30 | — | — | EP | disclosed |
| US-20080076931-A1 | OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF | ITAGAKI MAKOTO | 2008-03-27 | — | — | US | disclosed |
| US-20080076941-A1 | OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF | ITAGAKI MAKOTO | 2008-03-27 | — | — | US | disclosed |
| US-7288674-B2 | Optically active bisoxazoline compounds, process for production of the same and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-10-30 | — | — | US | disclosed |
| US-20070032659-A1 | Process for producing optically active cyclopropane compound and asymmetric copper complex for use in the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-02-08 | — | — | US | disclosed |
| US-20060149077-A1 | Optically active bisoxazoline compounds, process for production of the same and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-07-06 | — | — | US | disclosed |
| EP-1674445-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE CYCLOPROPANE COMPOUND AND ASYMMETRIC COPPER COMPLEX FOR USE IN THE SAME | Sumitomo Chemical Company, Limited (JP) | 2006-06-28 | — | — | EP | disclosed |
| EP-1593674-A1 | OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF | Sumitomo Chemical Company, Limited (JP) | 2005-11-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060149077-A1 | Optically active bisoxazoline compounds, process for production of the same and use thereof | ACSL3, ADSL, SQLE | HCAR2 1905/4885ATM 3625/4885NAAA 1659/4885 |
| US-12571157-B2 | Fluorocarbon chain-free hydrophobic fabric, preparation and application thereof | FFAR4, FFAR1, FFAR2 | HCAR2 620/4885ATM 2608/4885NAAA 122/4885 |
| US-20250092008-A1 | PROCESS FOR MAKING AN EP4 ANTAGONIST | PTGER4, LTB4R2, EPB41 | HCAR2 61/4885ATM 4453/4885NAAA 1322/4885 |
| US-20080076941-A1 | OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF | ACSL3, ADSL, SQLE | HCAR2 1905/4885ATM 3625/4885NAAA 1659/4885 |
| US-20070032659-A1 | Process for producing optically active cyclopropane compound and asymmetric copper complex for use in the same | CBR3, AOC3, CBR1 | HCAR2 275/4885ATM 4661/4885NAAA 1766/4885 |
| US-20080076931-A1 | OPTICALLY ACTIVE BISOXAZOLINE COMPOUNDS, PROCESS FOR PRODUCTION OF THE SAME AND USE THEREOF | ACSL3, ADSL, SQLE | HCAR2 1905/4885ATM 3625/4885NAAA 1659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.